Guo Ming Chen
Chairman bei MICROPORT CARDIOFLOW MEDTECH CORPORATION
Vermögen: 107 268 $ am 31.03.2024
Profil
Gegenwärtig ist Guo Ming Chen President & Executive Director bei MicroPort CardioFlow Medtech Corp. und General Manager & Director bei Shanghai MicroPort CardioFlow Medtech Co., Ltd. In seiner früheren Karriere hatte er die Position des Managers für Forschung und Entwicklung bei Shanghai Microport Medical (Group) Co., Ltd. inne. Herr Chen erhielt einen Bachelor- und einen Master-Abschluss von der Shanghai Jiao Tong University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.07.2023 | 742 954 ( 0,03% ) | 107 268 $ | 31.03.2024 |
Aktive Positionen von Guo Ming Chen
| Unternehmen | Position | Beginn |
|---|---|---|
| MICROPORT CARDIOFLOW MEDTECH CORPORATION | Chairman | 29.08.2023 |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
 Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Chairman | 29.08.2023 |
Ehemalige bekannte Positionen von Guo Ming Chen
| Unternehmen | Position | Ende |
|---|---|---|
Shanghai Microport Medical (Group) Co., Ltd.
 Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | Chief Tech/Sci/R&D Officer | 01.08.2016 |
Ausbildung von Guo Ming Chen
| Shanghai Jiao Tong University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MICROPORT CARDIOFLOW MEDTECH CORPORATION | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Shanghai Microport Medical (Group) Co., Ltd.
Shanghai Microport Medical (Group) Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Shanghai Microport Medical (Group) Co. Ltd. develops, manufactures, and markets medical products for interventional cardiology and peripheral vascular diseases. The company’s products include cardiovascular, endovascular, neurovascular, peripheral vascular, coronary stent systems, balloon catheters, peripheral and cardiac retractors. The company’s products are used in cardiac catheter laboratories. The company was founded in 1998 and is based in Shanghai, China. | Electronic Technology |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Health Technology |
